{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:02:18Z","timestamp":1790866938746,"version":"4.1.0"},"publisher-location":"Boston","reference-count":65,"publisher":"Kluwer Academic Publishers","isbn-type":[{"value":"1402079192","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/1-4020-7920-6_2","type":"book-chapter","created":{"date-parts":[[2006,1,12]],"date-time":"2006-01-12T13:40:45Z","timestamp":1137073245000},"page":"13-43","source":"Crossref","is-referenced-by-count":14,"title":["Myelodysplastic\/Myeloproliferative Diseases"],"prefix":"10.1007","author":[{"given":"James W.","family":"Vardiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"J.M. Bennett","year":"1982","unstructured":"Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189\u2013199.","journal-title":"Br J Haematol"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/10428199309148501","volume":"9","author":"J.L. Michaux","year":"1993","unstructured":"Michaux J.L., Martiat P. Chronic myelomonocytic leukaemia (CMML) \u2014 a myelodysplastic or myeloproliferative syndrome? Leuk Lymph 1993;9:35\u201341.","journal-title":"Leuk Lymph"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10428199909058471","volume":"34","author":"B.J. Bain","year":"1999","unstructured":"Bain B.J. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders. Leuk Lymphoma 1999;34:443\u2013449.","journal-title":"Leuk Lymphoma"},{"key":"2_CR4","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","year":"2001","unstructured":"Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001."},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0145-2126(96)00028-8","volume":"20","author":"R. Neuwirtov\u00e1","year":"1996","unstructured":"Neuwirtov\u00e1 R., Mocikov\u00e1 K., Musilov\u00e1 J., et al. Mixed myelodysplastic and myeloproliferative syndromes. Leuk Res 1996;20:717\u2013726.","journal-title":"Leuk Res"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/1357-4310(96)10044-7","volume":"2","author":"P.D. Emanuel","year":"1996","unstructured":"Emanuel P.D., Shannon K.M., Castleberry R.P. Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy. Mol Med Today 1996;2:468\u2013475.","journal-title":"Mol Med Today"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.leu.2402765","volume":"17","author":"H. Hasle","year":"2003","unstructured":"Hasle H., Niemeyer C.M., Chessells J.M., et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative disease. Leukemia 2003;17:277\u2013282.","journal-title":"Leukemia"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood.V74.8.2629.2629","volume":"74","author":"P.C. Cogswell","year":"1989","unstructured":"Cogswell P.C., Morgan R., Dunn M., et al. Mutations of the Ras protooncogenes in chronic myelogenous leukemia: a high frequency of Ras mutations in bcr\/abl rearrangement-negative chronic myelogenous leukemia. Blood 1989;74:2629\u20132633.","journal-title":"Blood"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood.V76.6.1214.1214","volume":"76","author":"C. Hirsch-Ginsberg","year":"1990","unstructured":"Hirsch-Ginsberg C., LeMaistre A.C., Kantarjian H., et al. RAS mutations are rare events in Philadelphia chromosome-negative\/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia. Blood 1990;76:1214\u20131219.","journal-title":"Blood"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","volume":"92","author":"L.E. Side","year":"1998","unstructured":"Side L.E., Emanuel P.D., Taylor B., et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 1998;92:267\u2013272.","journal-title":"Blood"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1156","volume":"34","author":"M. Tartaglia","year":"2003","unstructured":"Tartaglia M., Niemeyer C.M., Fragele A., et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003;34:148\u2013150.","journal-title":"Nat Genet"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"T.R. Golub","year":"1994","unstructured":"Golub T.R., Barker G.F., Lovett M., et al. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307\u2013316.","journal-title":"Cell"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1073\/pnas.93.25.14845","volume":"93","author":"M. Carroll","year":"1996","unstructured":"Carroll M., Tomasson M.H., Barker G.F., et al. The TEL\/platelet-derived growth factor beta receptor (PDGFbetaR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFbeta R kinase-dependent signaling pathways. Proc Natl Acad Sci USA 1996:93:145\u2013150.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood.V93.5.1707","volume":"93","author":"M.H. Tomasson","year":"1999","unstructured":"Tomasson M.H., Williams I.R., Hasserjian R., et al. TEL\/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood 1999;93:1707\u20131714.","journal-title":"Blood"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00001622-200201000-00003","volume":"14","author":"L. Kelly","year":"2002","unstructured":"Kelly L., Clark. J, Gilliland D.G. Comprehensive genetic analysis of leukemia: clinical and therapeutic implications. Cur Opinion Oncol 2002;14:10\u201318.","journal-title":"Cur Opinion Oncol"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2141.1999.01435.x","volume":"103","author":"P.D. Emanuel","year":"1999","unstructured":"Emanuel P.D. Myelodysplasia and myeloproliferative disorders in children: an update. Review. Br J Haematol 1999;103:852\u2013863.","journal-title":"Br J Haematol"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0145-2126(82)90042-X","volume":"6","author":"T. Suda","year":"1982","unstructured":"Suda T., Miura Y., Mizoguchi H., et al. Characterization of hematopoietic precursor cells in juvenile-type chronic myelocytic leukemia. Leuk Res 1982;6:43\u201353.","journal-title":"Leuk Res"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","volume":"77","author":"P.D. Emanuel","year":"1991","unstructured":"Emanuel P.D., Bates L.J., Castleberry R.P., et al. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991;77:925\u2013929.","journal-title":"Blood"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V85.1.21.bloodjournal85121","volume":"85","author":"L. Busque","year":"1995","unstructured":"Busque L., Gilliland D.G., Prachal J.T., et al. Clonality in juvenile chronic myelomonocytic leukemia. Blood 1995;85:21\u201330.","journal-title":"Blood"},{"key":"2_CR20","first-page":"306","volume":"25","author":"R.W. Freeburn","year":"1997","unstructured":"Freeburn R.W., Gale R.E., Wagner H.M., Linch D.C. Analysis of the coding sequence for the GM-CSF receptor alpha and beta chains in patients with juvenile chronic myeloid leukemia (JCML). Exp Hematol 1997;25:306\u2013311.","journal-title":"Exp Hematol"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.V83.8.2248.2248","volume":"83","author":"J. Miyauchi","year":"1994","unstructured":"Miyauchi J., Asada M., Sasaki M., et al. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 1994;83:2248\u20132254.","journal-title":"Blood"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.leu.2401240","volume":"13","author":"C. Flotho","year":"1999","unstructured":"Flotho C., Valcamonica S., Mach-Pascual S., et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999;13:32\u201337.","journal-title":"Leukemia"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJM199706123362404","volume":"336","author":"L. Side","year":"1997","unstructured":"Side L., Taylor B., Cayouette M., et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Eng J Med 1997;336:1713\u20131720.","journal-title":"N Eng J Med"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V78.1.205.205","volume":"78","author":"P. Martiat","year":"1991","unstructured":"Martiat P., Michaux J.L., Rodhain J. for the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique. Philadelphia-negative (Ph\u2212) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. Blood 1991;78:205\u2013211.","journal-title":"Blood"},{"issue":"Suppl.1","key":"2_CR25","first-page":"567","volume":"78","author":"P.D. Emanuel","year":"1991","unstructured":"Emanuel P.D., Zhu S.W., Bates L.J., Zuckerman K.S. Hypersensitivity to hemopoietic growth factors in chronic myelomonocytic leukemia. Blood 1991;78(Suppl.1), 567a.","journal-title":"Blood"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00282-997-0041-4","volume":"39","author":"N. Cambier","year":"1997","unstructured":"Cambier N., Baruchei A., Schlageter M.H., et al. Chronic myelomonocytic leukemia: from biology to therapy. Hematology and Cell Therapy 1997;39:41\u201348.","journal-title":"Hematology and Cell Therapy"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0301-472X(02)00903-7","volume":"30","author":"H.S. Ramshaw","year":"2002","unstructured":"Ramshaw H.S., Bardy P.G., Lee M.A., et al. Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulation factor for growth in vitro and in vivo. Exp Hematol 2002;30:1124\u20131131.","journal-title":"Exp Hematol"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1182\/blood.V99.3.840","volume":"99","author":"F. Onida","year":"2002","unstructured":"Onida F., Kantarjian H.M., Smith T.L., et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002;99:840\u2013849.","journal-title":"Blood"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-4608(91)90235-M","volume":"55","author":"Groupe Francais de Cytogenetique Hematologique","year":"1991","unstructured":"Groupe Francais de Cytogenetique Hematologique. Chronic myelomonocytic leukemia: Single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Cancer Genet Cytogenet 1991;55:57\u201365.","journal-title":"Cancer Genet Cytogenet"},{"key":"2_CR30","first-page":"499","volume":"7","author":"K. Toyama","year":"1993","unstructured":"Toyama K., Ohyashiki K., Yoshida Y., Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 1993;7:499\u2013508.","journal-title":"Leukemia"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1182\/blood.V91.12.4419","volume":"91","author":"T.S. Ross","year":"1998","unstructured":"Ross T.S., Bernard O.A., Berger R., Gilliland D.G. Fusion of Huntingtin interacting protein 1 to platelet derived growth factor beta receptor (PDGFbetareceptor) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood 1998;91:4419\u20134426.","journal-title":"Blood"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1182\/blood-2002-01-0165","volume":"100","author":"M.K. Magnusson","year":"2002","unstructured":"Magnusson M.K., Meade K.E., Nakamura R., et al. Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene. Blood 2002;100:1088\u20131091.","journal-title":"Blood"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0301-472X(00)00138-7","volume":"28","author":"A.M. Wilbanks","year":"2000","unstructured":"Wilbanks A.M., Mahajan S., Frank D.A., et al. TEL\/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins. Exp Hematol 2000;28:584\u2013593.","journal-title":"Exp Hematol"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1023\/A:1008311532043","volume":"11","author":"J.M. Hernandez","year":"2000","unstructured":"Hernandez J.M., del Canizo M.C., Cuneo A., et al. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol 2000;11:441\u2013444.","journal-title":"Ann Oncol"},{"key":"2_CR35","first-page":"134a","volume":"10","author":"N. Shukralla","year":"1997","unstructured":"Shukralla N., Finiewicz K., Roulston D., et al. Is atypical chronic myeloid leukemia a high white count myelodysplastic disorder? Mod Pathol 1997;10:134a.","journal-title":"Mod Pathol"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/hmg\/11.12.1391","volume":"11","author":"E.J. Baxter","year":"2002","unstructured":"Baxter E.J., Hochhaus A., Bolufer P., et al. The t(4;22)(q12;q11) in atypical chronic myeloid leukemia fuses BCR to PDGFRalpha. Human Mol Genet 2002;11:1391\u20131397.","journal-title":"Human Mol Genet"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1038\/sj.onc.1206543","volume":"22","author":"P. Trempat","year":"2003","unstructured":"Trempat P., Villalva C., Laurent G., et al. Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571\/Glivec. Oncogene 2003;22:5702\u20135706.","journal-title":"Oncogene"},{"key":"2_CR38","first-page":"369","volume":"84","author":"S. Siena","year":"1999","unstructured":"Siena S., Sammarelli G., Grimoldi M.G., et al. New reciprocal translocation t(5;10)q33;q22) associated with atypical chronic myeloid leukemia. Haematologica 1999;84:369\u2013372.","journal-title":"Haematologica"},{"key":"2_CR39","first-page":"149","volume":"40","author":"J. Aurich","year":"1998","unstructured":"Aurich J., Duchayne E., Huguet-Rigal F., et al. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias. Hematol Cel Ther 1998;40:149\u2013158.","journal-title":"Hematol Cel Ther"},{"key":"2_CR40","first-page":"3534","volume":"89","author":"C.M. Niemeyer","year":"1997","unstructured":"Niemeyer C.M., Arico M., Biondi A., et al. Chronic myelomonocytic leukemia in childhood: A retrospective analysis of 110 cases. Blood 1997;89:3534\u20133543.","journal-title":"Blood"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.leu.2401342","volume":"13","author":"H. Hasle","year":"1999","unstructured":"Hasle H., Arico M., Biondi A., et al. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. Leukemia 1999;13:376\u2013385.","journal-title":"Leukemia"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V90.2.479","volume":"90","author":"M. Arico","year":"1997","unstructured":"Arico M., Biondi A., Pui C.H. Juvenile myelomonocytic leukemia. Blood 1997;90:479\u2013488.","journal-title":"Blood"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V91.1.365","volume":"91","author":"D. Pinkel","year":"1998","unstructured":"Pinkel D. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998;91:365\u2013367.","journal-title":"Blood"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V91.1.365","volume":"91","author":"C.M. Niemeyer","year":"1998","unstructured":"Niemeyer C.M., Fenu S., Hasle H., et al. Response (letter); Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998;91:365\u2013367.","journal-title":"Blood"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.V93.2.459","volume":"93","author":"S. Luna-Fineman","year":"1999","unstructured":"Luna-Fineman S., Shannon K.M., Atwater S.K., et al. Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients. Blood 1999;93:459\u2013466.","journal-title":"Blood"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/ajcp\/105.2.238","volume":"105","author":"J.L. Hess","year":"1996","unstructured":"Hess J.L., Zutter M.M., Castleberry R.P., Emanuel P.D., Juvenile chronic myelogenous leukemia. Am J Clin Pathol 1996; 105:238\u2013248.","journal-title":"Am J Clin Pathol"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood.V61.6.1098.1098","volume":"61","author":"H. Herrod","year":"1983","unstructured":"Herrod H., Dow L., Sullivan J. Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: Immunologic and hematologic studies. Blood 1983;61:1098\u20131105.","journal-title":"Blood"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","volume":"87","author":"J.M. Bennett","year":"1994","unstructured":"Bennett J.M., Catovsky D., Daniel M.T., et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994;87:746\u2013754.","journal-title":"Br J Haematol"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0145-2126(97)00192-6","volume":"22","author":"U. Germing","year":"1998","unstructured":"Germing U., Gattermann N., Minning H., et al. Problems in the classification of CMML\u2014dysplastic versus proliferative type. Leuk Res 1998;22:871\u2013878.","journal-title":"Leuk Res"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0145-2126(00)00159-4","volume":"25","author":"J. Voglov\u00e1","year":"2001","unstructured":"Voglov\u00e1 J., Chrob\u00e1k L., Neuwirtov\u00e1 R., et al. Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia-distinct subgroups or two stages of the same disease? Leuk Res 2001;25:493\u2013499.","journal-title":"Leuk Res"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1200\/JCO.1988.6.9.1417","volume":"6","author":"P. Fenaux","year":"1988","unstructured":"Fenaux P., Beuscart R., Lai J.L., et al. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. J Clin Oncol 1988;6:1417\u20131424.","journal-title":"J Clin Oncol"},{"key":"2_CR52","first-page":"766","volume":"4","author":"A.M. Storniolo","year":"1990","unstructured":"Storniolo A.M., Moloney W.C., Rosenthal D.S., et al. Chronic myelomonocytic leukemia. Leukemia 1990;4:766\u2013770.","journal-title":"Leukemia"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1080\/1042819021000016186","volume":"43","author":"M.W. Saif","year":"2002","unstructured":"Saif M.W., Hopkins J.L., Gore S.D. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymph 2002;43:2083\u20132092.","journal-title":"Leuk Lymph"},{"key":"2_CR54","first-page":"95","volume":"33","author":"P.A. Kouides","year":"1996","unstructured":"Kouides P.A., Bennett J.M. Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol 1996;33:95\u2013110.","journal-title":"Semin Hematol"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.1992.tb01587.x","volume":"48","author":"H. Maschek","year":"1992","unstructured":"Maschek H., Georgii A., Kaloutsi V., et al. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur J Haematol 1992;48:208\u2013214.","journal-title":"Eur J Haematol"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/1097-0142(19920315)69:6<1457::AID-CNCR2820690625>3.0.CO;2-F","volume":"69","author":"F.K. Baddoura","year":"1992","unstructured":"Baddoura F.K., Hanson C., Chan W.C. Plasmacytoid monocyte proliferation associated with myeloproliferative disorders. Cancer 1992;69:1457\u20131467.","journal-title":"Cancer"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00000478-199101000-00011","volume":"15","author":"N.L. Harris","year":"1991","unstructured":"Harris N.L., Demirjian Z. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization. Am J Surg Pathol 1991;15:87\u201395.","journal-title":"Am J Surg Pathol"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.1987.tb06142.x","volume":"65","author":"P. Fenaux","year":"1987","unstructured":"Fenaux P., Jouet J.P., Zandecki M., et al. Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol 1987;65:101\u2013106.","journal-title":"Br J Haematol"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V63.3.634.634","volume":"63","author":"P. Solal-Celigny","year":"1984","unstructured":"Solal-Celigny P., Desaint B., Herrera A., et al. Chronic myelomonocytic leukemia according to the FAB classification: analysis of 35 cases. Blood 1984;63:634\u2013638.","journal-title":"Blood"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0950-3536(87)80031-8","volume":"1","author":"P.C.A. Shepherd","year":"1987","unstructured":"Shepherd P.C.A., Ganesan T.S., Galton D.A.G. Haematological classification of the chronic myeloid leukaemias. Bailliere\u2019s Clinical Haematology 1987;1:887\u2013906.","journal-title":"Bailliere\u2019s Clinical Haematology"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1365-2141.1996.396933.x","volume":"92","author":"D.G. Oscier","year":"1996","unstructured":"Oscier D.G. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome? Br J Haematol 1996;92:582\u2013586.","journal-title":"Br J Haematol"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.1988.tb02433.x","volume":"70","author":"P. Felman","year":"1988","unstructured":"Felman P., Bryon P.A., Gentilhomme O., et al. The syndrome of abnormal chromatin clumping in leucocytes: a myelodysplastic disorder with proliferative features? Br J Haematol 1988;70:49\u201354.","journal-title":"Br J Haematol"},{"key":"2_CR63","first-page":"532","volume":"75","author":"R. Invernizzi","year":"1990","unstructured":"Invernizzi R., Custodi P., De Fazio P., et al. The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. Haematologica 1990;75:532\u2013536.","journal-title":"Haematologica"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2141.1989.tb07703.x","volume":"72","author":"A. Brizard","year":"1989","unstructured":"Brizard A., Huret J.L., Lamotte J.I., et al. Three cases of myelodysplastic-myeloproliferative disorder with abnormal chromatin clumping in granulocytes. Correspondence. Br J Haematol 1989;72:294\u2013295.","journal-title":"Br J Haematol"},{"key":"2_CR65","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"B. Bain","year":"2001","unstructured":"Bain B., Vardiman J.W., Imbert M., Pierre R. Myelodysplastic\/myeloproliferative disease, unclassifiable, in Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001."}],"container-title":["Cancer Treatment and Research","Hematopathology in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/1-4020-7920-6_2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T16:19:13Z","timestamp":1619540353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/1-4020-7920-6_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["1402079192"],"references-count":65,"URL":"https:\/\/doi.org\/10.1007\/1-4020-7920-6_2","relation":{},"subject":[]}}